Investment
Features
FeesSafety
Academy
More
Pluang+

Law firm investigates Perpetua Resources officers for possible shareholder rights breaches

Market News
17 Aug 2026
PRNewsWire
View Source
Bearish
Law firm investigates Perpetua Resources officers for possible shareholder rights breaches

Halper Sadeh LLC is investigating whether officers and directors of Perpetua Resources Corp. breached their fiduciary duties to shareholders. Long-term shareholders may seek reforms, financial awards, or other relief if misconduct is found. The firm offers free consultations and works on a contingency fee basis, urging shareholders to act quickly due to possible time limits. This investigation aims to improve corporate governance and protect shareholder value.

More News

MillerKnoll beats profit estimates with $0.53 EPS despite revenue decline in Q1 2027.

MillerKnoll beats profit estimates with $0.53 EPS despite revenue decline in Q1 2027.

MillerKnoll reported a strong Q1 2027 earnings per share (EPS) of $0.53, surpassing analyst expectations by over 51%, helped by tariff refunds and improved cost management. However, its revenue fell 3.4% year-over-year to $923.40 million, missing est...

Company Fundamentals
Neutral
2 hours ago
THOR Industries misses Q4 EPS estimates but beats revenue expectations amid RV market challenges

THOR Industries misses Q4 EPS estimates but beats revenue expectations amid RV market challenges

THOR Industries reported Q4 earnings with an EPS of $0.78, missing analyst estimates and showing a 66.9% drop from last year. Despite this, the company beat revenue expectations with $2.31 billion, though revenue declined 8.4% year-over-year due to w...

Company Fundamentals
Bearish
3 hours ago
Cracker Barrel earnings expected to drop sharply in Q3 2026, with EPS forecast at $0.17 and revenue down.

Cracker Barrel earnings expected to drop sharply in Q3 2026, with EPS forecast at $0.17 and revenue down.

Cracker Barrel Old Country Store is set to report its Q3 2026 earnings on September 23, with analysts predicting a significant decline. Earnings per share are expected to fall to $0.17 from $0.74 last year, and revenue is forecasted around $834.57 mi...

Company Fundamentals
Bearish
3 hours ago
Viking Therapeutics jumps 26.5% on strong GLP-1 obesity drug data, while peers show little reaction.

Viking Therapeutics jumps 26.5% on strong GLP-1 obesity drug data, while peers show little reaction.

Viking Therapeutics surged 26.5% after releasing positive topline results from its GLP-1/GIP agonist VK2735 maintenance dosing study in adults with obesity. The data suggest multiple effective maintenance dosing schedules, potentially improving patie...

Market News
Bullish
4 hours ago
Abivax gains FDA nod for Obefazimod, backed by strong cash and positive analyst outlook.

Abivax gains FDA nod for Obefazimod, backed by strong cash and positive analyst outlook.

Abivax received positive pre-NDA feedback from the U.S. FDA for its drug Obefazimod, marking a key step in its development. Despite a recent price target cut by Wedbush to $118, analysts maintain a "Moderate Buy" consensus with an average target of $...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App